Literature DB >> 32399380

Preparation, characterization, and anticancer efficacy of novel cobalt oxide nanoparticles conjugated with thiosemicarbazide.

Mahsa Jarestan1, Kimia Khalatbari1, Ayda Pouraei2, Seyed Ataollah Sadat Shandiz3, Sadaf Beigi1, Mohammad Hedayati4, Amitis Majlesi1, Fatemeh Akbari5, Ali Salehzadeh1.   

Abstract

Gastric cancer is one of the most common cancers in modern societies. Previous studies have shown that the use of nanoparticle complexes is effective in the treatment of cancer. The aim of this study was to investigate the cytotoxicity and anticancer properties of cobalt oxide (Co3O4) nanoparticles (NPs) functionalized by glutamic acid (Glu) and conjugated with thiosemicarbazide (TSC) on gastric cancer (AGS) cell line. First, the Co3O4@Glu/TSC nanoparticles were synthesized via co-condensation reaction. Fourier-transform infrared (FTIR), X-ray diffraction (XRD), scanning electron microscopy (SEM) and energy dispersive X-ray (EDX) tests were performed for identifying the morphology, structure, size and functional groups of produced nanoparticles. MTT assay was also performed to evaluate cytotoxicity effect. Moreover, Annexin V/PI staining with flow cytometry analysis, caspase-3 activation assay, and Hoechst 33258 staining was carried out for evaluating apoptosis. The FTIR results showed that the components of Co3O4@Glu/TSC NPs complex were successfully fabricated. Crystallographic structure of Co3O4@Glu/TSC NPs was confirmed by XRD patterns. SEM results indicated that the size of the nanoparticles was in the range of 16-40 nm. An EDX spectrum was determined and data explained the existence of cobalt as the prominent element. MTT test results showed that AGS cell life was significantly decreased compared to the control group with increasing concentration of nanoparticles (dose-dependent) (P < 0.05), IC50 = 107.5 μg/mL. The results of flow cytometry assay and caspase-3 activity showed that fabricated Co3O4@Glu/TSC NPs induced apoptosis in the treated group. Moreover, Co3O4@Glu/TSC NPs treated AGS cells indicate an increase in the apoptotic characteristics including nuclear fragmentation. In the current work, the promising cytotoxicity and anti-cancer activities of Co3O4@Glu/TSC NPs complex toward gastric cancer (AGS) cell line were showed and it can be suggested for the drug delivery system. © King Abdulaziz City for Science and Technology 2020.

Entities:  

Keywords:  AGS; Cobalt oxide; Gastric cancer; Glutamic acid; Thiosemicarbazide

Year:  2020        PMID: 32399380      PMCID: PMC7200957          DOI: 10.1007/s13205-020-02230-4

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  24 in total

1.  Gene expression in nanotoxicology research: analysis by differential display in BALB3T3 fibroblasts exposed to cobalt particles and ions.

Authors:  Elena Papis; Rosalba Gornati; Mariangela Prati; Jessica Ponti; Enrico Sabbioni; Giovanni Bernardini
Journal:  Toxicol Lett       Date:  2007-03-13       Impact factor: 4.372

Review 2.  Advances in cobalt complexes as anticancer agents.

Authors:  Catherine R Munteanu; Kogularamanan Suntharalingam
Journal:  Dalton Trans       Date:  2015-08-21       Impact factor: 4.390

Review 3.  Gastric cancer: epidemiologic aspects.

Authors:  Carlos A González; Núria Sala; Theodore Rokkas
Journal:  Helicobacter       Date:  2013-09       Impact factor: 5.753

Review 4.  H. pylori infection and gastric cancer: state of the art (review).

Authors:  Vincenza Conteduca; Domenico Sansonno; Gianfranco Lauletta; Sabino Russi; Giuseppe Ingravallo; Franco Dammacco
Journal:  Int J Oncol       Date:  2012-11-15       Impact factor: 5.650

5.  Phosphonomethyl iminodiacetic acid-conjugated cobalt oxide nanoparticles liberate Co(++) ion-induced stress associated activation of TNF-α/p38 MAPK/caspase 8-caspase 3 signaling in human leukemia cells.

Authors:  Sourav Chattopadhyay; Sandeep Kumar Dash; Satyajit Tripathy; Panchanan Pramanik; Somenath Roy
Journal:  J Biol Inorg Chem       Date:  2014-12-23       Impact factor: 3.358

Review 6.  Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity.

Authors:  R A Finch; M C Liu; A H Cory; J G Cory; A C Sartorelli
Journal:  Adv Enzyme Regul       Date:  1999

7.  Synthesis, structural characterization and antimicrobial activities of 4- and 6-coordinate nickel(II) complexes with three thiosemicarbazones and semicarbazone ligands.

Authors:  N C Kasuga; K Sekino; C Koumo; N Shimada; M Ishikawa; K Nomiya
Journal:  J Inorg Biochem       Date:  2001-03       Impact factor: 4.155

8.  Synthesis, characterization, and antibacterial activity of novel Mn(II), Co(II), Ni(II), Cu(II), and Zn(II) complexes with vitamin K3-thiosemicarbazone.

Authors:  Q X Li; H A Tang; Y Z Li; M Wang; L F Wang; C G Xia
Journal:  J Inorg Biochem       Date:  2000-01-30       Impact factor: 4.155

Review 9.  Medical application of functionalized magnetic nanoparticles.

Authors:  Akira Ito; Masashige Shinkai; Hiroyuki Honda; Takeshi Kobayashi
Journal:  J Biosci Bioeng       Date:  2005-07       Impact factor: 2.894

10.  Effect of cobalt(II) chloride hexahydrate on some human cancer cell lines.

Authors:  Sonia Mahey; Rakesh Kumar; Rohit Arora; Jyoti Mahajan; Saroj Arora; Renu Bhardwaj; Ashwani Kumar Thukral
Journal:  Springerplus       Date:  2016-06-30
View more
  3 in total

1.  Determination of anticancer potential of a novel pharmacologically active thiosemicarbazone derivative against colorectal cancer cell lines.

Authors:  Azmat Ali Khan; Rehan Ahmad; Amer M Alanazi; Nawaf Alsaif; Maha Abdullah; Tanveer A Wani; Mashooq A Bhat
Journal:  Saudi Pharm J       Date:  2022-03-31       Impact factor: 4.562

2.  CoO Nanozymes with Multiple Catalytic Activities Regulate Atopic Dermatitis.

Authors:  Mao Mao; Xuejiao Guan; Feng Wu; Lan Ma
Journal:  Nanomaterials (Basel)       Date:  2022-02-14       Impact factor: 5.076

Review 3.  Novel Drug Delivery Systems as an Emerging Platform for Stomach Cancer Therapy.

Authors:  Umme Hani; Riyaz Ali M Osmani; Sabina Yasmin; B H Jaswanth Gowda; Hissana Ather; Mohammad Yousuf Ansari; Ayesha Siddiqua; Mohammed Ghazwani; Adel Al Fatease; Ali H Alamri; Mohamed Rahamathulla; M Yasmin Begum; Shadma Wahab
Journal:  Pharmaceutics       Date:  2022-07-29       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.